Author:
Martín Francisco,Tristán-Manzano María,Maldonado-Pérez Noelia,Sánchez-Hernández Sabina,Benabdellah Karim,Cobo Marién
Reference49 articles.
1. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315–317
2. Hwang BW, Kim SJ, Park KM et al (2015) Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels. J Control Release 220(Pt A):119–129
3. Park SA, Ryu CH, Kim SM et al (2011) CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 38(1):97–103
4. Tyciakova S, Matuskova M, Bohovic R et al (2015) Genetically engineered mesenchymal stromal cells producing TNFalpha have tumour suppressing effect on human melanoma xenograft. J Gene Med 17(1–2):54–67
5. Sasportas LS, Kasmieh R, Wakimoto H et al (2009) Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A 106(12):4822–4827
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献